Literature DB >> 6894972

Optic nerve involvement in dysthyroidism.

J D Trobe.   

Abstract

Although its prevalence in dysthyroidism is estimated at less than 5%, optic neuropathy should be recognized as a preventable cause of disabling visual loss. Obscured by more obvious external congestive signs, it is usually insidiously progressive and bilateral, but may be acute and unilateral. Neuro-ophthalmic findings are nonspecific (prechiasmal field defects, normal or swollen nerveheads), and the diagnosis should be suspected in the context of typical adnexal changes of dysthyroidism. Optic nerve involvement is probably secondary to apical orbital compression by congested muscles. Treatment with oral corticosteroids, irradiation, or orbital decompression has been beneficial, especially in the early phases.

Entities:  

Mesh:

Year:  1981        PMID: 6894972     DOI: 10.1016/s0161-6420(81)34997-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  23 in total

1.  Reversal of dysthyroid optic neuropathy following orbital fat decompression.

Authors:  M Kazim; S L Trokel; G Acaroglu; A Elliott
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

Review 2.  [Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy].

Authors:  A Eckstein; J Esser
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

3.  Contrast sensitivity and the diagnosis dysthyroid optic neuropathy.

Authors:  M P Mourits; M S Suttorp-Schulten; R O Tijssen; P Apkarian
Journal:  Doc Ophthalmol       Date:  1990 Apr-Jul       Impact factor: 2.379

4.  Early diagnosis of Graves' optic neuropathy using visual evoked responses.

Authors:  J A Batch; F Lepre
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

5.  [Clinical and neuroradiological diagnostics in Graves' orbitopathy].

Authors:  F Beisse; C Pieh-Beisse; W A Lagrèze; C Hader
Journal:  Ophthalmologe       Date:  2011-05       Impact factor: 1.059

6.  Effects of bilateral orbital decompression by an endoscopic endonasal approach in dysthyroid orbitopathy.

Authors:  A Neugebauer; K Nishino; P Neugebauer; W Konen; O Michel
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

7.  Measuring contrast sensitivity in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.

Authors:  R De Marco; G Ambrosio; G Ferrara
Journal:  Doc Ophthalmol       Date:  2000-09       Impact factor: 2.379

8.  Hyperthyroidism associated with papilloedema and pyramidal tract involvement.

Authors:  S Ono; S Morooka; N Shimizu; N Shimizu
Journal:  J Neurol       Date:  1987-10       Impact factor: 4.849

9.  Mesenchymal Stem Cell-Like Properties of Orbital Fibroblasts in Graves' Orbitopathy.

Authors:  Katarzyna Kozdon; Caroline Fitchett; Geoffrey E Rose; Daniel G Ezra; Maryse Bailly
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

Review 10.  Graves' ophthalmopathy.

Authors:  W E Barrie
Journal:  West J Med       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.